Literature DB >> 28849018

MicroRNA-199b targets the regulation of ZEB1 expression to inhibit cell proliferation, migration and invasion in non‑small cell lung cancer.

Jin Wang1, Fachen Zhou1, Liu Yin1, Lei Zhao1, Yixiang Zhang1, Jinguang Wang1.   

Abstract

Lung cancer is one of the leading causes of cancer-associated mortality worldwide. Previous evidence suggested that microRNAs (miRs) exhibit important regulatory roles in tumorigenesis and tumor development, including in non‑small cell lung cancer (NSCLC). The present study investigated the expression of miR‑199b in NSCLC tissues and cell lines, in addition to the biological roles of miR‑199b in the carcinogenesis and progression of NSCLC. The results of the present study demonstrated that miR‑199b expression was decreased in NSCLC tissues and cell lines compared with matched adjacent healthy tissues and a healthy human bronchial epithelial cell line, respectively. An MTT assay demonstrated that the viability of NSCLC cells was decreased by miR‑199b. The migratory and invasive abilities of NSCLC cells were suppressed by miR‑199b overexpression. In addition, zinc finger E‑box‑binding homeobox 1 (ZEB1) was identified to be a novel direct downstream and functional target for miR‑199b in NSCLC, using bioinformatics analysis, luciferase reporter assay, the reverse transcription‑quantitative polymerase chain reaction and western blotting. ZEB1 underexpression mimicked the roles of miR‑199b overexpression in NSCLC cells. In conclusion, the present study demonstrated that miR‑199b was downregulated in NSCLC and acted as a tumor suppressor by targeting ZEB1.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28849018     DOI: 10.3892/mmr.2017.7195

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   3.423


  6 in total

1.  MiR-101 inhibits the proliferation and metastasis of lung cancer by targeting zinc finger E-box binding homeobox 1.

Authors:  Le Han; Wenjuan Chen; Yanmin Xia; Yangrong Song; Zheng Zhao; Hao Cheng; Tao Jiang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 2.  Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer.

Authors:  Sawsan Rashdan; Puneeth Iyengar; John D Minna; David E Gerber
Journal:  Transl Lung Cancer Res       Date:  2021-07

3.  Integrative Transcriptomic Analysis Reveals a Multiphasic Epithelial-Mesenchymal Spectrum in Cancer and Non-tumorigenic Cells.

Authors:  Nicholas Panchy; Cassandra Azeredo-Tseng; Michael Luo; Natalie Randall; Tian Hong
Journal:  Front Oncol       Date:  2020-01-22       Impact factor: 6.244

Review 4.  MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.

Authors:  Milad Ashrafizadeh; Hui Li Ang; Ebrahim Rahmani Moghadam; Shima Mohammadi; Vahideh Zarrin; Kiavash Hushmandi; Saeed Samarghandian; Ali Zarrabi; Masoud Najafi; Reza Mohammadinejad; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-07-12

Review 5.  MicroRNAs as crucial mediators in the pharmacological activities of triptolide (Review).

Authors:  Kun Zhou; Yinxia Chang; Bo Han; Rui Li; Yanming Wei
Journal:  Exp Ther Med       Date:  2021-03-17       Impact factor: 2.447

6.  Down-Regulation of ZEB1 by miR-199a-3p Overexpression Restrains Tumor Stem-Like Properties and Mitochondrial Function of Non-Small Cell Lung Cancer.

Authors:  Juan Bai; Wen-Yu Jiao
Journal:  Onco Targets Ther       Date:  2020-05-22       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.